Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (34)

2024

  1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

    eBioMedicine, Vol. 102

  2. Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  3. Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study

    Oral Diseases, Vol. 30, Núm. 2, pp. 149-162

  4. Prognostic value of preoperative inflammatory ratios in early glottic cancer treated with transoral laser surgery

    Head and Neck, Vol. 46, Núm. 4, pp. 819-830

  5. Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma

    European Archives of Oto-Rhino-Laryngology, Vol. 281, Núm. 2, pp. 945-951

  6. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

    Nature Communications, Vol. 14, Núm. 1

  2. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

  3. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

    Molecular Cancer, Vol. 22, Núm. 1

  4. Chemo-Immunotherapy: A New Trend in Cancer Treatment

    Cancers, Vol. 15, Núm. 11

  5. Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma

    Redox Biology, Vol. 62

  6. Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells

    Free Radical Biology and Medicine, Vol. 209, pp. 127-134

  7. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  8. Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer

    Biomedicines, Vol. 11, Núm. 1

  9. Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †

    Cancers, Vol. 15, Núm. 3

  10. Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis †

    Cancers, Vol. 15, Núm. 3

  11. Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer

    Biomedicines, Vol. 11, Núm. 10

  12. Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †

    Biomedicines, Vol. 11, Núm. 8

2022

  1. Addressing Doxorubicin Resistance in Bone Sarcomas using Novel Drug‐Resistant Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. An intrinsic temporal order of c-JUN N-terminal phosphorylation regulates its activity by orchestrating co-factor recruitment

    Nature Communications, Vol. 13, Núm. 1